Bank of Montreal
INFI

Bank of Montreal’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bank of Montreal’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-19,600
Closed -$331K – 4248
2014
Q4 		$331K Buy
+19,600
New +$285K ﹤0.01% 2251
2014
Q1 		– Sell
-32,800
Closed -$453K – 4190
2013
Q4 		$453K Buy
+32,800
New +$463K ﹤0.01% 1858

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Bank of Montreal's INFI Position: Q2 2019 in Review

Bank of Montreal sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2019, closing a stake of 400 shares — an estimated $1K sold.

Bank of Montreal first reported a position in INFI in Q4 2013 and held it in 8 quarters. The position peaked at $608K in Q4 2014. 55 funds tracked by Wall St. Rank hold INFI as of Q2 2019.

  • Bank of Montreal reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Bank of Montreal sold 400 Infinity Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1K.
  • Bank of Montreal first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2013 and held it in 8 quarters.
  • Bank of Montreal's Infinity Pharmaceuticals, Inc. position peaked at $608K in Q4 2014.
  • 55 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2019.

Based on Bank of Montreal's 13F filing for Q2 2019, filed 9 Aug 2019.